4//SEC Filing
Zanganeh Mahkam 4
Accession 0001507650-26-000003
CIK 0001599298other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:52 PM ET
Size
6.5 KB
Accession
0001507650-26-000003
Insider Transaction Report
Form 4
Zanganeh Mahkam
DirectorCo-Chief Executive Officer10% Owner
Transactions
- Award
Stock Option (right to buy)
2026-01-02$8.76/sh+11,232$98,392→ 11,232 total(indirect: By Spouse)Exercise: $17.52Exp: 2036-01-02→ Common Stock (11,232 underlying)
Footnotes (3)
- [F1]The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person's spouse remaining as a non-salaried director on each such vesting date.
- [F2]The option was issued to the reporting person's spouse pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $98,400.
- [F3]The reporting person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or any other purpose.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001507650
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:52 PM ET
- Size
- 6.5 KB